Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imiquimod for Bowen's Disease of the Head and Neck
NCT00384124Phase 3Unknown
- Sponsor
- Brooke Army Medical Center
- Start
- Nov 2006
- Primary completion
- Nov 2008
- Modality
- Nucleic Acid-Directed Small Molecules, Irreversible Covalent Inhibitors, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of imiquimod in squamous cell carcinoma in situ (SCCIS), sponsored by Brooke Army Medical Center. Status: unknown.
02
Drugs
imiquimod
03
Conditions
squamous cell carcinoma in situ (SCCIS)
Beyond the preview
Go deeper on NCT00384124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00384124.